Warburg Pincus’s Outset Medical OM Stock Holding History

Warburg Pincus’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-56,099	Closed	-$42.1M	–	12
2021 Q2	$42.1M	Sell	56,099 -259,381	-82%	-$198M	0.9%	11
2021 Q1	$257M	Hold	315,480	–	–	5.47%	4
2020 Q4	$269M	Sell	315,480 -282,611	-47%	-$218M	4.61%	5
2020 Q3	$449M	Buy	+598,091	New	+$491M	29.96%	1

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Warburg Pincus's OM Position: Q3 2021 in Review

Warburg Pincus sold out of Outset Medical (OM) in Q3 2021, closing a stake of 56,099 shares — an estimated $42.1M sold.

Warburg Pincus first reported a position in OM in Q3 2020 and held it in 4 quarters. The position peaked at $449M in Q3 2020. 142 funds tracked by Wall St. Rank hold OM as of Q3 2021.

Warburg Pincus reported no remaining Outset Medical position as of Q3 2021 after selling out during the quarter.
Warburg Pincus sold 56,099 Outset Medical shares in Q3 2021, an estimated $42.1M.
Warburg Pincus first reported a position in Outset Medical in Q3 2020 and held it in 4 quarters.
Warburg Pincus's Outset Medical position peaked at $449M in Q3 2020.
142 funds tracked by Wall St. Rank held Outset Medical as of Q3 2021.

Based on Warburg Pincus's 13F filing for Q3 2021, filed 15 Nov 2021.